109 related articles for article (PubMed ID: 1985910)
1. Cellular expression of mutant insulin receptors interferes with the rapid transcriptional response to both insulin and insulin-like growth factor I.
Stumpo DJ; Blackshear PJ
J Biol Chem; 1991 Jan; 266(1):455-60. PubMed ID: 1985910
[TBL] [Abstract][Full Text] [Related]
2. Mutation of the two carboxyl-terminal tyrosines results in an insulin receptor with normal metabolic signaling but enhanced mitogenic signaling properties.
Takata Y; Webster NJ; Olefsky JM
J Biol Chem; 1991 May; 266(14):9135-9. PubMed ID: 2026614
[TBL] [Abstract][Full Text] [Related]
3. Insulin receptors with defective tyrosine kinase inhibit normal receptor function at the level of substrate phosphorylation.
Maegawa H; Olefsky JM; Thies S; Boyd D; Ullrich A; McClain DA
J Biol Chem; 1988 Sep; 263(25):12629-37. PubMed ID: 2970462
[TBL] [Abstract][Full Text] [Related]
4. Augmented mitogenesis and impaired metabolic signaling mediated by a truncated insulin receptor.
Thies RS; Ullrich A; McClain DA
J Biol Chem; 1989 Aug; 264(22):12820-5. PubMed ID: 2753889
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of impaired metabolic signaling by a truncated human insulin receptor. Decreased activation of protein phosphatase 1 by insulin.
Begum N; Olefsky JM; Draznin B
J Biol Chem; 1993 Apr; 268(11):7917-22. PubMed ID: 8385127
[TBL] [Abstract][Full Text] [Related]
6. Intracellular signaling by a mutant human insulin receptor lacking the carboxyl-terminal tyrosine autophosphorylation sites.
Takata Y; Webster NJ; Olefsky JM
J Biol Chem; 1992 May; 267(13):9065-70. PubMed ID: 1577744
[TBL] [Abstract][Full Text] [Related]
7. Insulin and growth factor effects on c-fos expression in normal and protein kinase C-deficient 3T3-L1 fibroblasts and adipocytes.
Stumpo DJ; Blackshear PJ
Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9453-7. PubMed ID: 3540941
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction pathways leading to insulin-induced early gene induction.
Jhun BH; Haruta T; Meinkoth JL; Leitner W; Draznin B; Saltiel AR; Pang L; Sasaoka T; Olefsky JM
Biochemistry; 1995 Jun; 34(25):7996-8004. PubMed ID: 7540866
[TBL] [Abstract][Full Text] [Related]
9. Insulin activates nuclear factor kappa B in mammalian cells through a Raf-1-mediated pathway.
Bertrand F; Philippe C; Antoine PJ; Baud L; Groyer A; Capeau J; Cherqui G
J Biol Chem; 1995 Oct; 270(41):24435-41. PubMed ID: 7592658
[TBL] [Abstract][Full Text] [Related]
10. Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation.
Harada S; Smith RM; Smith JA; White MF; Jarett L
J Biol Chem; 1996 Nov; 271(47):30222-6. PubMed ID: 8939974
[TBL] [Abstract][Full Text] [Related]
11. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways.
Miele C; Rochford JJ; Filippa N; Giorgetti-Peraldi S; Van Obberghen E
J Biol Chem; 2000 Jul; 275(28):21695-702. PubMed ID: 10777488
[TBL] [Abstract][Full Text] [Related]
12. Identification of c-fos sequences involved in induction by insulin and phorbol esters.
Stumpo DJ; Stewart TN; Gilman MZ; Blackshear PJ
J Biol Chem; 1988 Feb; 263(4):1611-4. PubMed ID: 3276673
[TBL] [Abstract][Full Text] [Related]
13. A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis.
McClain DA; Maegawa H; Lee J; Dull TJ; Ulrich A; Olefsky JM
J Biol Chem; 1987 Oct; 262(30):14663-71. PubMed ID: 3312193
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of enhanced transmembrane signaling by an insulin receptor lacking a cytoplasmic beta-subunit domain.
Sasaoka T; Langlois WJ; Rose DW; Olefsky JM
J Biol Chem; 1995 May; 270(18):10885-92. PubMed ID: 7738028
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I induction of c-myc expression in bovine fibroblasts can be blocked by antecedent insulin receptor activation.
Conover CA; Bale LK
Exp Cell Res; 1998 Jan; 238(1):122-7. PubMed ID: 9457064
[TBL] [Abstract][Full Text] [Related]
16. Rapid events in growth hormone action. Induction of c-fos and c-jun transcription in 3T3-F442A preadipocytes.
Gurland G; Ashcom G; Cochran BH; Schwartz J
Endocrinology; 1990 Dec; 127(6):3187-95. PubMed ID: 2123448
[TBL] [Abstract][Full Text] [Related]
17. Control of c-fos and c-myc proto-oncogene induction in rat thyroid cells in culture.
Isozaki O; Kohn LD
Mol Endocrinol; 1987 Nov; 1(11):839-48. PubMed ID: 2856403
[TBL] [Abstract][Full Text] [Related]
18. Adrenergic regulation of c-fos expression in cultured BC3H1 muscle cells.
Barka T; van der Noen H; Gresik EW
Exp Cell Res; 1989 Dec; 185(2):419-35. PubMed ID: 2557227
[TBL] [Abstract][Full Text] [Related]
19. Dissection of the growth versus metabolic effects of insulin and insulin-like growth factor-I in transfected cells expressing kinase-defective human insulin receptors.
McClain DA; Maegawa H; Thies RS; Olefsky JM
J Biol Chem; 1990 Jan; 265(3):1678-82. PubMed ID: 2153140
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor I signalling through heterodimers of insulin and insulin-like growth factor I receptors.
Takata Y; Kobayashi M
Diabete Metab; 1994; 20(1):31-6. PubMed ID: 8056133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
